We are live on
!
Find out more
CM
CM Management Portfolio holdings
AUM
$157M
Turnover
30.95%
1-Year Est. Return
60.08%
This Fund
S&P 500
This Quarter
Est. Return
+16.31%
1 Year Est. Return
+60.08%
3 Year Est. Return
+110.48%
5 Year Est. Return
+186.03%
10 Year Est. Return
–
AUM
$135M
AUM Growth
+$26.7M
(+25%)
Cap. Flow
+$13.4M
Cap. Flow
% of AUM
9.95%
Top 10 Holdings %
Top 10 Hldgs %
35.95%
Holding
101
New
21
Increased
28
Reduced
9
Closed
20
Avg Time Held
0.2
years
Top 10 Avg Time Held
0.2
years
Top 20 Avg Time Held
0.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amicus Therapeutics
FOLD
|
+$5.57M |
| 2 |
Alico
ALCO
|
+$2.28M |
| 3 |
Elicio Therapeutics
ELTX
|
+$1.81M |
| 4 |
Exelixis
EXEL
|
+$1.81M |
| 5 |
Merck
MRK
|
+$1.47M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aterian
ATER
|
+$7.86M |
| 2 |
Aviat Networks
AVNW
|
+$3.95M |
| 3 |
ClearPoint Neuro
CLPT
|
+$3.34M |
| 4 |
Intel
INTC
|
+$2.49M |
| 5 |
Gilead Sciences
GILD
|
+$1.75M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 40.52% |
| 2 | Financials | 13.92% |
| 3 | Technology | 12.69% |
| 4 | Energy | 10.02% |
| 5 | Materials | 6.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
AMCON Distributing
DIT
$58.6M
| $340K | 0.25% |
4,448
| – | – |
2020 Q4
1 quarter
|
|
|
CRTD
77
DELISTED
Creatd Inc. Common Stock
CRTD
| $323K | 0.24% |
75,000
-88,000
| -54% | -$421K |
2020 Q4
1 quarter
|
|
78
DELISTED
ARKO Corp Warrant
ARKOW
| $308K | 0.23% |
+150,000
| New | +$265K |
2021 Q1
0 quarters
|
|
79
Teva Pharmaceutical Industries Limited
TEVA
$47.9B
| $289K | 0.21% |
+25,000
| New | +$287K |
2021 Q1
0 quarters
|
|
80
DELISTED
Petros Pharmaceuticals
PTPI
| $168K | 0.12% |
180
| – | – |
2020 Q4
1 quarter
|
|
|
CRTDW
81
DELISTED
Creatd Inc. Warrant
CRTDW
| $18K | 0.01% |
+9,042
| New | +$18.7K |
2021 Q1
0 quarters
|
|
82
Amneal Pharmaceuticals
AMRX
$6.7B
| – | – |
-125,000
| Closed | -$571K | – |
|
83
American Superconductor
AMSC
$1.3B
| – | – |
-19,589
| Closed | -$459K | – |
|
|
84
Aviat Networks
AVNW
$250M
| – | – |
-231,536
| Closed | -$3.95M | – |
|
85
Casey's General Stores
CASY
$24.9B
| – | – |
-1,000
| Closed | -$179K | – |
|
86
Cathay General Bancorp
CATY
$4.01B
| – | – |
-15,000
| Closed | -$483K | – |
|
|
87
ClearPoint Neuro
CLPT
$294M
| – | – |
-210,000
| Closed | -$3.34M | – |
|
88
Evolus
EOLS
$500M
| – | – |
-46,620
| Closed | -$157K | – |
|
|
89
Gilead Sciences
GILD
$195B
| – | – |
-30,000
| Closed | -$1.75M | – |
|
90
Huntington Ingalls Industries
HII
$10.5B
| – | – |
-1,000
| Closed | -$170K | – |
|
|
91
Intel
INTC
$504B
| – | – |
-50,000
| Closed | -$2.49M | – |
|
92
Lantern Pharma
LTRN
$9.96M
| – | – |
-10,000
| Closed | -$193K | – |
|
93
Lumen Technologies, Inc. Common Stock
LUMN
$5.02B
| – | – |
-30,000
| Closed | -$293K | – |
|
94
Filana Therapeutics
FLNA
$36.8M
| – | – |
-175,000
| Closed | -$1.19M | – |
|
95
Simon Property Group
SPG
$65.8B
| – | – |
-5,000
| Closed | -$426K | – |
|
|
SVC
96
Service Properties Trust
SVC
$802M
| – | – |
-10,000
| Closed | -$575K | – |
|
97
DELISTED
Warner Bros
WBD
| – | – |
-30,000
| Closed | -$903K | – |
|
98
Zedge
ZDGE
$43M
| – | – |
-40,000
| Closed | -$242K | – |
|
99
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| – | – |
-25,000
| Closed | -$795K | – |
|
100
DELISTED
Territorial Bancorp Inc.
TBNK
| – | – |
-11,132
| Closed | -$268K | – |
|
Similar funds
SFSG
PTFIS
AWMG
LDNAM
DFS
APW
GA
TC
CM Management's Q1 2021 Portfolio in Review
As of Q1 2021, CM Management held 101 positions worth $135M, up 25% from $108M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
CM Management deployed $13.4M of net new capital in Q1 2021, opening 21 new positions and adding to 28 existing holdings. Its largest new stake was Elicio Therapeutics: 9,375 shares worth $1.69M.
By sector, the portfolio is most concentrated in Healthcare at 41% of assets, up from 37% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Aterian, an estimated $7.86M trimmed.
- CM Management's largest Q1 2021 buy was Elicio Therapeutics: 9,375 shares worth $1.69M.
- CM Management added most to Amicus Therapeutics in Q1 2021, an estimated $5.57M increase.
- CM Management's biggest Q1 2021 reduction was Aterian, cutting an estimated $7.86M.
- CM Management fully exited Aviat Networks in Q1 2021, selling an estimated $3.95M.
- CM Management's ten largest holdings make up 36% of its $135M portfolio in Q1 2021.
- CM Management opened 21 new positions and closed 20 in Q1 2021.
- CM Management's portfolio value rose 25% quarter-over-quarter to $135M.
Based on CM Management's 13F filing for Q1 2021, filed 12 May 2021.